Bloodstream infections in cancer patients with febrile neutropenia

International Journal of Antimicrobial Agents

Volumn 32, Issue SUPPL. 1, 2008, Pages

  Feld, Ronald ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Bacteraemia; Febrile neutropenia; Predictive laboratory markers

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; INTERLEUKIN 6; INTERLEUKIN 8; MANNOSE BINDING LECTIN; PROCALCITONIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTEREMIA; BLOODSTREAM INFECTION; CANCER CHEMOTHERAPY; CANCER PATIENT; DEVELOPING COUNTRY; ESCHERICHIA COLI; FEBRILE NEUTROPENIA; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; GRAM NEGATIVE SEPSIS; GRAM POSITIVE BACTERIUM; HEMATOLOGIC MALIGNANCY; HIGH RISK PATIENT; HUMAN; KLEBSIELLA; LABORATORY TEST; LYMPHOMA; MORTALITY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; PSEUDOMONAS AERUGINOSA; SOLID TUMOR;

ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; NEOPLASMS; NEUTROPENIA; PROGNOSIS;

EID: 54049101062     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.06.017     Document Type: Article

References (18)

1. Viscoli C., Bruzzi P., Castagnola E., et al. Factors associated with bacteraemia in febrile, granulocytopenic cancer patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer 30A (1994) 430-437
2. Frère P., Baron F., Bonnet C., et al. Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen. Bone Marrow Transplant 37 (2006) 411-418
3. Nørgaard M., Larsson H., Pedersen G., Schønheyder H.C., and Sørensen H.T. Risk of bacteraemia and mortality in patients with haematological malignancies. Clin Microbiol Infect 12 (2006) 217-223
4. Toussaint E., Bahel-Ball E., Vekemans M., et al. Causes of fever in cancer patients (prospective study over 477 episodes). Support Care Cancer 14 (2006) 763-769
5. Viscoli C., Cometta A., Kern W.V., et al. Piperacillin-tazobactam monotherapy in high-risk febrile neutropenic cancer patients. Clin Microbiol Infect 12 (2006) 212-216
6. Elting L.S., Rubenstein E.B., Rolston K.V.I., and Bodey G.P. Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clin Infect Dis 25 (1997) 247-259
7. Klastersky J. Science and pragmatism in the treatment and prevention of neutropenic infection. J Antimicrob Chemother 41 (1998) 13-24
8. Ramphal R. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens. Clin Infect Dis 39 suppl. 1 (2004) S25-S31
9. Cruciani M., Rampazzo R., Malena M., et al. Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis. Clin Infect Dis 23 (1996) 795-805
10. Klastersky J., Ameye L., Maertens J., et al. Bacteraemia in febrile neutropenic cancer patients. Int J Antimicrob Agents 30 suppl. 1 (2007) S51-S59
11. Klastersky J., Paesmans M., Rubenstein E.B., et al. The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18 (2000) 3038-3051
12. Hughes W.T., Armstrong D., Bodey G.P., et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34 (2002) 730-751
13. Kanafani Z.A., Dakdouki G.K., El-Chammas K.I., Eid S., Araj G.F., and Kanj S.S. Bloodstream infections in febrile neutropenic patients at a tertiary care center in Lebanon: a view of the past decade. Int J Infect Dis 11 (2007) 450-453
14. Baskaran N.D., Gan G.G., Adeeba K., and Sam I.C. Bacteremia in patients with febrile neutropenia after chemotherapy at a university medical center in Malaysia. Int J Infect Dis 6 (2007) 513-517
15. Vekemans M., Robinson J., Georgala A., et al. Low mannose-binding lectin concentration is associated with severe infection in patients with hematological cancer who are undergoing chemotherapy. Clin Infect Dis 44 (2007) 1593-1601
16. Schlapbach L.J., Aebi C., Otth M., Leibundgut K., Hirt A., and Ammann R.A. Deficiency of mannose-binding lectin-associated serine protease-2 associated with increased risk of fever and neutropenia in pediatric cancer patients. Pediatr Infect Dis J 11 (2007) 989-994
17. Kern W.V. Risk assessment and treatment of low-risk patients with febrile neutropenia. Clin Infect Dis 42 (2006) 533-540
18. Diepold M., Noellke P., Duffner U., Kontny U., and Berner R. Performance of interleuken-6 and interleukin-8 serum levels in pediatric oncology patients with neutropenia and fever for the assessment of low-risk. BMC Infect Dis 8 (2008) 28